GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer
GRHL3 is a factor associated with a tumor, of which the molecular mechanism remains a further investigation. We explored the underlying mechanism of tumor-promoting effect of GRHL3 in colorectal cancer (CRC), which is involved in the MEK1/2 pathway. The expression of GRHL3 was measured in CRC and ad...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2021/6004821 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562834403229696 |
|---|---|
| author | Lin Tan Weiming Qu Dajun Wu Minji Liu Qian Wang Qiongjia Ai Hongsai Hu Min Chen Weishun Chen Hongbing Zhou |
| author_facet | Lin Tan Weiming Qu Dajun Wu Minji Liu Qian Wang Qiongjia Ai Hongsai Hu Min Chen Weishun Chen Hongbing Zhou |
| author_sort | Lin Tan |
| collection | DOAJ |
| description | GRHL3 is a factor associated with a tumor, of which the molecular mechanism remains a further investigation. We explored the underlying mechanism of tumor-promoting effect of GRHL3 in colorectal cancer (CRC), which is involved in the MEK1/2 pathway. The expression of GRHL3 was measured in CRC and adjacent normal tissue using qPCR and immunohistochemical staining. Lentivirus-mediated knockdown expression of GRHL3 was performed in the CRC cell line HT29. Cell proliferation and metastasis were assayed in vitro, and tumorigenicity was investigated in vivo. We found higher GRHL3 expression in colorectal cancer, which was negatively correlated with patients’ prognosis. Results from studies in vitro and in vivo indicated that downregulation of GRHL3 expression inhibited tumor growth and metastasis and inhibited the activation of the MEK1/2 pathway. The effect of GRHL3 downexpression was the same as that of MEK1/2 antagonists on suppression of tumor growth and metastasis. Our results suggested that GRHL3 may act as an oncogene to promote tumor growth and metastasis via the MEK pathway in colorectal cancer. |
| format | Article |
| id | doaj-art-aef82da3b9b54c7f856de132fdb9573f |
| institution | Kabale University |
| issn | 2210-7185 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Analytical Cellular Pathology |
| spelling | doaj-art-aef82da3b9b54c7f856de132fdb9573f2025-02-03T01:21:45ZengWileyAnalytical Cellular Pathology2210-71852021-01-01202110.1155/2021/6004821GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal CancerLin Tan0Weiming Qu1Dajun Wu2Minji Liu3Qian Wang4Qiongjia Ai5Hongsai Hu6Min Chen7Weishun Chen8Hongbing Zhou9Department of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyGRHL3 is a factor associated with a tumor, of which the molecular mechanism remains a further investigation. We explored the underlying mechanism of tumor-promoting effect of GRHL3 in colorectal cancer (CRC), which is involved in the MEK1/2 pathway. The expression of GRHL3 was measured in CRC and adjacent normal tissue using qPCR and immunohistochemical staining. Lentivirus-mediated knockdown expression of GRHL3 was performed in the CRC cell line HT29. Cell proliferation and metastasis were assayed in vitro, and tumorigenicity was investigated in vivo. We found higher GRHL3 expression in colorectal cancer, which was negatively correlated with patients’ prognosis. Results from studies in vitro and in vivo indicated that downregulation of GRHL3 expression inhibited tumor growth and metastasis and inhibited the activation of the MEK1/2 pathway. The effect of GRHL3 downexpression was the same as that of MEK1/2 antagonists on suppression of tumor growth and metastasis. Our results suggested that GRHL3 may act as an oncogene to promote tumor growth and metastasis via the MEK pathway in colorectal cancer.http://dx.doi.org/10.1155/2021/6004821 |
| spellingShingle | Lin Tan Weiming Qu Dajun Wu Minji Liu Qian Wang Qiongjia Ai Hongsai Hu Min Chen Weishun Chen Hongbing Zhou GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer Analytical Cellular Pathology |
| title | GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer |
| title_full | GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer |
| title_fullStr | GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer |
| title_full_unstemmed | GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer |
| title_short | GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer |
| title_sort | grhl3 promotes tumor growth and metastasis via the mek pathway in colorectal cancer |
| url | http://dx.doi.org/10.1155/2021/6004821 |
| work_keys_str_mv | AT lintan grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT weimingqu grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT dajunwu grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT minjiliu grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT qianwang grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT qiongjiaai grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT hongsaihu grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT minchen grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT weishunchen grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer AT hongbingzhou grhl3promotestumorgrowthandmetastasisviathemekpathwayincolorectalcancer |